Cargando…
Limited comparability of creatinine assays in patients with liver cirrhosis and their impact on the MELD score
BACKGROUND & AIM: Patients with end-stage liver disease require valid estimations of mortality for organ allocation and risk stratification. The model of end-stage liver disease (MELD) score is used for this purpose in most countries and incorporates bilirubin, International Normalized ratio, an...
Autores principales: | Kaiser, Thorsten, Kinny-Köster, Benedict, Gnewuch, Carsten, Karailieva, Diana, Kiehntopf, Michael, Kessler, Anja, Ritter-Sket, Christina, Schmidt, Michael, Brand, Korbinian, Thiery, Joachim, Lichtinghagen, Ralf |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5575426/ https://www.ncbi.nlm.nih.gov/pubmed/28856226 http://dx.doi.org/10.1016/j.plabm.2017.04.002 |
Ejemplares similares
-
Impact of Different Creatinine Measurement Methods on Liver Transplant Allocation
por: Kaiser, Thorsten, et al.
Publicado: (2014) -
Low sphingosine-1-phosphate plasma levels are predictive for increased mortality in patients with liver cirrhosis
por: Becker, Susen, et al.
Publicado: (2017) -
Plasma Amino Acid Concentrations Predict Mortality in Patients with End-Stage Liver Disease
por: Kinny-Köster, Benedict, et al.
Publicado: (2016) -
Inclusion of Sarcopenia Within MELD (MELD-Sarcopenia) and the Prediction of Mortality in Patients With Cirrhosis
por: Montano-Loza, Aldo J, et al.
Publicado: (2015) -
MELD-GRAIL-Na Is a Better Predictor of Mortality Than MELD in Korean Patients with Cirrhosis
por: Kim, Jung-Woo, et al.
Publicado: (2023)